In recent years, genetic engineering and protein expression technologies have promoted the development of recombinant protein vaccines. To accelerate the development of efficient vaccines for mycosis, screening candidate antigens, and determining the optimal route of administration are indispensable steps. Two methods for identifying novel antigens and producing antigens specific to Candida albicans, as a model causative pathogen of mycosis, are discussed in this chapter. Specifically, the application of liquid chromatography/tandem mass spectrometry using a long monolithic column for proteome analysis to identify virulence factors of C. albicans, followed by molecular display technology to produce an oral vaccine using antigens found by the proteomic study, is described.
CITATION STYLE
Shibasaki, S., & Ueda, M. (2017). Preparation of an oral vaccine by proteome analysis and molecular display technology. In Methods in Molecular Biology (Vol. 1625, pp. 237–245). Humana Press Inc. https://doi.org/10.1007/978-1-4939-7104-6_16
Mendeley helps you to discover research relevant for your work.